Published in N Engl J Med on May 25, 1989
The evolving role of endoscopic treatment for bleeding esophageal varices. World J Surg (2005) 1.21
Management of variceal haemorrhage. BMJ (1994) 0.96
A multicentre randomised trial comparing octreotide and injection sclerotherapy in the management and outcome of acute variceal haemorrhage. Gut (1997) 0.92
Somatostatin in acute bleeding oesophageal varices. Clinical evidence. Drugs (1992) 0.91
Variceal recurrence, rebleeding, and survival after endoscopic injection sclerotherapy in 287 alcoholic cirrhotic patients with bleeding esophageal varices. Ann Surg (2006) 0.89
Liver transplantation in patients with previous portasystemic shunt. Am J Surg (1990) 0.86
Management of portal hypertension in children. World J Gastroenterol (2012) 0.85
Liver transplantation in a randomized controlled trial of emergency treatment of acutely bleeding esophageal varices in cirrhosis. Transplant Proc (2010) 0.81
Emergency portacaval shunt versus rescue portacaval shunt in a randomized controlled trial of emergency treatment of acutely bleeding esophageal varices in cirrhosis--part 3. J Gastrointest Surg (2010) 0.78
Influence of extravariceal collateral channel pattern on recurrence of esophageal varices after sclerotherapy. J Gastroenterol (1997) 0.78
A prospective randomized controlled clinical trial comparing the effects of somatostatin and vasopressin for control of acute variceal bleeding in the patients with liver cirrhosis. Korean J Intern Med (2003) 0.75
Successful use of a transjugular intrahepatic portosystemic stent shunt to control severe refractory oesophageal variceal haemorrhage in a poor risk patient. Postgrad Med J (1993) 0.75
Controversies in the management of bleeding esophageal varices. N Engl J Med (1989) 0.75
Transabdominal gastro-esophageal devascularization and esophageal transection for bleeding esophageal varices after failed injection sclerotherapy: long-term follow-up report. World J Surg (2006) 0.75
Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol (2001) 19.07
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol (1999) 9.11
Carcinoid tumour. Lancet (1998) 4.52
Nine scoring models for short-term mortality in alcoholic hepatitis: cross-validation in a biopsy-proven cohort. Aliment Pharmacol Ther (2014) 3.98
Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC. Cancer Treat Rev (2007) 2.75
Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy. J Hepatol (2010) 2.50
Anti-tuberculosis medication and the liver: dangers and recommendations in management. Eur Respir J (1995) 2.39
Bacterial infection in the pathogenesis of variceal bleeding. Lancet (1999) 2.35
A prospective study of biliary cytology in 100 patients with bile duct strictures. Hepatology (1993) 2.34
The Eurotransplant donor risk index in liver transplantation: ET-DRI. Am J Transplant (2012) 2.29
An evaluation of emergency sclerotherapy of varices in randomized trials: looking the needle in the eye. Endoscopy (2006) 2.22
Coagulation and fibrosis in chronic liver disease. Gut (2008) 2.22
Systematic review and meta-analysis of intraoperative versus preoperative endoscopic sphincterotomy in patients with gallbladder and suspected common bile duct stones. Br J Surg (2011) 2.13
Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis. N Engl J Med (1983) 2.10
Risk factors, sequential organ failure assessment and model for end-stage liver disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit. Aliment Pharmacol Ther (2006) 2.00
Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis. Lancet (1999) 1.98
"Salvage" transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding. Gastroenterology (1998) 1.95
Transjugular intrahepatic portosystemic shunt versus endoscopic therapy: randomized trials for secondary prophylaxis of variceal bleeding: an updated meta-analysis. Scand J Gastroenterol (2002) 1.92
A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis. Gastroenterology (2002) 1.90
An appraisal of the histopathological assessment of liver fibrosis. Gut (2006) 1.87
Systematic review: The model for end-stage liver disease--should it replace Child-Pugh's classification for assessing prognosis in cirrhosis? Aliment Pharmacol Ther (2005) 1.86
Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. Lancet (1996) 1.78
A predictive model for failure to control bleeding during acute variceal haemorrhage. J Hepatol (1999) 1.76
Change in occurrence of paracetamol overdose in UK after introduction of blister packs. Lancet (2000) 1.75
Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology (1998) 1.74
Prevention of first bleeding in cirrhosis. A meta-analysis of randomized trials of nonsurgical treatment. Ann Intern Med (1992) 1.72
Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis. Gut (1998) 1.63
Treatment outcomes for hepatocellular carcinoma using chemoembolization in combination with other therapies. Cancer Treat Rev (2006) 1.63
Enhanced thrombin generation in patients with cirrhosis-induced coagulopathy. J Thromb Haemost (2010) 1.62
Transjugular liver biopsy: how good is it for accurate histological interpretation? Gut (2006) 1.61
Disseminated intravascular coagulation in liver cirrhosis: fact or fiction? Am J Gastroenterol (1999) 1.60
Review article: portal vein thrombosis -- new insights into aetiology and management. Aliment Pharmacol Ther (2005) 1.59
Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage. Hepatology (1998) 1.57
Biochemical criteria at 1 year are not robust indicators of response to ursodeoxycholic acid in early primary biliary cirrhosis: results from a 29-year cohort study. Aliment Pharmacol Ther (2013) 1.56
Azathioprine in liver transplantation: a reevaluation of its use and a comparison with mycophenolate mofetil. Am J Transplant (2009) 1.52
Diurnal pattern of variceal bleeding in cirrhotic patients. J Hepatol (1993) 1.47
Randomized controlled trial of tacrolimus versus microemulsified cyclosporin (TMC) in liver transplantation: poststudy surveillance to 3 years. Am J Transplant (2006) 1.47
Meta-analysis: ursodeoxycholic acid for primary sclerosing cholangitis. Aliment Pharmacol Ther (2011) 1.46
Review article: renal function assessment in cirrhosis - difficulties and alternative measurements. Aliment Pharmacol Ther (2007) 1.45
Therapeutic aspects of radio-isotopes in hepatobiliary malignancy. Br J Surg (1991) 1.45
In vitro assessment of Lipiodol-targeted radiotherapy for liver and colorectal cancer cell lines. Br J Cancer (1999) 1.42
Development of physical activity behaviors among children and adolescents. Pediatrics (1998) 1.41
Tacrolimus exposure after liver transplantation in randomized controlled trials: too much for too long. Am J Transplant (2013) 1.40
Systematic review of radiological imaging for hepatocellular carcinoma in cirrhotic patients. Br J Radiol (2004) 1.40
Infection, coagulation, and variceal bleeding in cirrhosis. Gut (2005) 1.39
Staple-line erosion: a common source of recurrent bleeding following stapled oesophageal transection. Br J Surg (1991) 1.39
Ultrasound screening for hepatocellular carcinoma (HCC) in cirrhosis: the evidence for an established clinical practice. Clin Radiol (1998) 1.38
Delayed diagnosis of biliary leak due to bile duct division during cholecystectomy. J R Coll Surg Edinb (1994) 1.37
LeVeen shunt with wandering tip. Lancet (1991) 1.36
Idiopathic acute fatty liver of pregnancy in 12 patients. Q J Med (1982) 1.36
Kinetics of cytomegalovirus load decrease in solid-organ transplant recipients after preemptive therapy with valganciclovir. J Infect Dis (2004) 1.35
Systematic review: portal vein thrombosis in cirrhosis. Aliment Pharmacol Ther (2009) 1.35
Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis. Hepatology (1999) 1.29
Definitions, methodology and therapeutic strategies in portal hypertension. A Consensus Development Workshop, Baveno, Lake Maggiore, Italy, April 5 and 6, 1990. J Hepatol (1992) 1.27
Female liver transplant recipients with the same GFR as male recipients have lower MELD scores--a systematic bias. Am J Transplant (2007) 1.25
Endoscopic extraction of bile duct stones: management related to stone size. Gut (1993) 1.24
Specialist training in the UK. Lancet (1998) 1.22
Bacteriuria and primary biliary cirrhosis. Gut (1984) 1.20
Cytomegalovirus replication kinetics in solid organ transplant recipients managed by preemptive therapy. Am J Transplant (2012) 1.19
Donor-specific bone marrow infusion after orthotopic liver transplantation. Lancet (1994) 1.18
A randomised phase II/III trial of 3-weekly cisplatin-based sequential transarterial chemoembolisation vs embolisation alone for hepatocellular carcinoma. Br J Cancer (2013) 1.17
Review article: scoring systems for assessing prognosis in critically ill adult cirrhotics. Aliment Pharmacol Ther (2006) 1.17
Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation. Aliment Pharmacol Ther (2006) 1.15
Hepatic artery thrombosis after orthotopic liver transplantation: a review of nonsurgical causes. Liver Transpl (2001) 1.15
Should we biopsy each liver mass suspicious for HCC before liver transplantation?--no, please don't. J Hepatol (2005) 1.15
Controversies in the management of bleeding esophageal varices (2) N Engl J Med (1989) 1.14
Distal spleno-renal shunt versus endoscopic sclerotherapy in the prevention of variceal rebleeding. A meta-analysis of 4 randomized clinical trials. J Hepatol (1992) 1.14
Treatment of small hepatocellular carcinomas. Lancet (1992) 1.13
In vivo and in vitro hepatic 31P magnetic resonance spectroscopy and electron microscopy of the cirrhotic liver. Liver (1997) 1.13
Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances. Hepatology (1995) 1.11
A comparison of sclerotherapy with staple transection of the esophagus for the emergency control of bleeding from esophageal varices. N Engl J Med (1989) 1.10
Bleeding time in patients with hepatic cirrhosis. BMJ (1990) 1.10
Hepatocellular ballooning after liver transplantation: a light and electronmicroscopic study with clinicopathological correlation. Histopathology (1991) 1.10
Why portal hypertensive varices bleed and bleed: a hypothesis. Gut (1995) 1.10
Molecular mimicry in liver disease. Nature (1992) 1.10
Reconstitution of EBV-specific T cell immunity in solid organ transplant recipients. J Immunol (1998) 1.09
Disopyramide and warfarin interaction. Br Med J (1977) 1.09
Reducing early exposure to calcineurin inhibitors: the key factor for a successful renal sparing strategy. Am J Transplant (2012) 1.09
Abdominal wall haematoma complicating laparoscopic cholecystectomy. HPB Surg (1994) 1.08
Long-standing asymptomatic primary sclerosing cholangitis: report of three cases. Dig Dis Sci (1981) 1.08
M2 mitochondrial antibodies and urinary rough mutant bacteria in patients with primary biliary cirrhosis and in patients with recurrent bacteriuria. J Hepatol (1993) 1.07
Nutritional status and prognosis in cirrhotic patients. Aliment Pharmacol Ther (2006) 1.06
The acute treatment of haemorrhage from oesophageal varices: a comparison of oesophageal transection and staple gun anastomosis with mesocaval shunt. Br J Surg (1981) 1.06
Gastric endoscopic features in portal hypertension: final report of a consensus conference, Milan, Italy, September 19, 1992. J Hepatol (1994) 1.05
Expression of beta-2-microglobulin on hepatocytes after liver transplantation. Lancet (1985) 1.04
A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancer. Ann Oncol (2013) 1.04
Human herpesviruses 6 and 7 as potential pathogens after liver transplant: prospective comparison with the effect of cytomegalovirus. J Med Virol (1999) 1.04
Desmopressin and bleeding time in patients with cirrhosis. Br Med J (Clin Res Ed) (1985) 1.03
Emergency transjugular intrahepatic portasystemic stent shunting as salvage treatment for uncontrolled variceal bleeding. Br J Surg (1994) 1.02
A giant cystic mesenchymal hamartoma of the liver: diagnosis, management, and study of cyst fluid. Gastroenterology (1983) 1.01
A comparison of transjugular and plugged-percutaneous liver biopsy in patients with impaired coagulation. J Hepatol (1993) 1.00
Safety of and necessity for needle biopsy of liver tumours. Lancet (1987) 1.00
The electronic information revolution and how to exploit it. Br J Surg (1992) 1.00
Analysis of intrapulmonary right to left shunt in the hepatopulmonary syndrome. J Hepatol (1998) 0.99